Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the ...

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

The age-adjusted cancer death rate has fallen since the 1990s, with the world winning the so-called "war on cancer." ...

A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.

Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and ...

The trial's principal investigator Pasi Janne said the results support osimertinib "as standard of care" for EGFR-mutated cancer patients. Janne also noted that AstraZeneca's drug "did not impose any ...

Patients using steroids, especially at high-doses, before taking immune checkpoint inhibitors for non–small cell lung cancer ...

Study compared use of chemotherapy and radiotherapy in 280,000 people from Britain, Australia, Norway and Canada ...

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...